Table 3.
Volumetric Analysis | Unidimensional | |||||
---|---|---|---|---|---|---|
Pre-Trace CT | Post-Trace CT | Linear CT | Linear US | CT | US | |
Tumor 1: Week8 | PR | PR | PR | PR | PR | SD |
Tumor 2: Week8 | PR | PR | PR | SD | SD | SD |
Tumor 3: Week8 | PR | PR | PR | SD | SD | SD |
Tumor 3: Week16 | PD | PD | PR | PR | PR | PR |
Tumor 4: Week8 | PR | PR | PR | PR | SD | PR |
Tumor 5: Week8 | PR | PR | SD | PR | SD | SD |
Tumor 5: Week16 | PD | PD | SD | PD | SD | SD |
Tumor 6: Week8 | PD | SD | PR | PD | SD | SD |
Tumor 6: Week16 | SD | SD | SD | SD | PR | SD |
Tumor 7: Week8 | PR | PR | PR | PR | SD | SD |
Tumor 7: Week16 | SD | PD | PD | SD | SD | SD |
Tumor 8: Week8 | PD | PD | SD | PD | SD | PD |
Tumor 9: Week8 | SD | SD | SD | SD | PD | SD |
Tumor 9: Week16 | SD | SD | SD | SD | SD | SD |
RECIST was applied to tumor volumes to compare to the unidimensional linear methods. A total of 9 tumors at 14 time points were available for rechecks. PR = partial response (solid gray), PD = progressive disease (solid black, white lettering), and SD = stable disease (solid white). One dog was not included in this table because it was only measured at one time point.